Hinge Health shares climb as investors appear to cheer post-earnings momentum

Hinge Health (HNGE) is up 11.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a positive reaction to Hinge Health’s August 4 earnings event, with investors appearing to reward continued growth and another boost to outlook. While a full same-day catalyst trail was not easy to confirm directly, the move fits the pattern of a strong earnings-driven repricing after the company had already been raising guidance earlier this summer.

Details:

Hinge Health told investors on July 6 that it would report second-quarter 2026 financial results after the market closed on August 4, setting up a likely earnings-related catalyst for the next trading day.

On June 9, the company raised its Q2 2026 revenue outlook to $200 million to $202 million and lifted full-year 2026 revenue guidance to $818 million to $824 million, signaling accelerating momentum before earnings.

In first-quarter 2026 results released in May, Hinge Health posted 47% year-over-year revenue growth to $182.3 million and also increased its full-year outlook, reinforcing the market’s focus on fast growth and expanding margins.

This could also be because investors interpreted the latest quarterly update as another beat-and-raise, extending confidence in demand for the company’s digital musculoskeletal care platform.

Sources:

Hinge Health Investor Relations, SEC, Yahoo Finance

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$HNGE Insider Trading Activity

$HNGE insiders have traded $HNGE stock on the open market 114 times in the past 6 months. Of those trades, 0 have been purchases and 114 have been sales.

Here’s a breakdown of recent trading of $HNGE stock by insiders over the last 6 months:

HOLDINGS GROUP, LLC INSIGHT has made 0 purchases and 68 sales selling 3,359,505 shares for an estimated $264,520,794.
GABRIEL M.I. MECKLENBURG has made 0 purchases and 17 sales selling 466,666 shares for an estimated $23,754,814.
DANIEL ANTONIO PEREZ (CEO & Co-Founder) sold 166,665 shares for an estimated $6,710,516
JAMES PURSLEY (President) has made 0 purchases and 12 sales selling 79,000 shares for an estimated $4,371,767.
JAMES BUDGE (Chief Financial Officer) has made 0 purchases and 10 sales selling 32,457 shares for an estimated $1,406,853.
ELLIOTT ROBINSON has made 0 purchases and 6 sales selling 0 shares for an estimated $0.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$HNGE Hedge Fund Activity

We have seen 127 institutional investors add shares of $HNGE stock to their portfolio, and 87 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DEER MANAGEMENT CO. LLC added 2,633,707 shares (+inf%) to their portfolio in Q1 2026, for an estimated $101,555,741
FULLER & THALER ASSET MANAGEMENT, INC. added 1,655,198 shares (+inf%) to their portfolio in Q1 2026, for an estimated $63,824,434
RTW INVESTMENTS, LP added 1,576,500 shares (+446.0%) to their portfolio in Q1 2026, for an estimated $60,789,840
AMERICAN CENTURY COMPANIES INC added 1,299,332 shares (+inf%) to their portfolio in Q1 2026, for an estimated $50,102,241
WALLEYE CAPITAL LLC added 1,160,801 shares (+1086.4%) to their portfolio in Q2 2026, for an estimated $96,346,483
ALYESKA INVESTMENT GROUP, L.P. removed 1,136,771 shares (-92.6%) from their portfolio in Q1 2026, for an estimated $43,833,889
JANE STREET GROUP, LLC removed 1,009,680 shares (-64.4%) from their portfolio in Q1 2026, for an estimated $38,933,260

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$HNGE Analyst Ratings

Wall Street analysts have issued reports on $HNGE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 02/11/2026
Canaccord Genuity issued a "Buy" rating on 02/11/2026

To track analyst ratings and price targets for $HNGE, check out Quiver Quantitative's $HNGE forecast page.

$HNGE Price Targets

Multiple analysts have issued price targets for $HNGE recently. We have seen 12 analysts offer price targets for $HNGE in the last 6 months, with a median target of $76.0.

Here are some recent targets:

Stan Berenshteyn from Wells Fargo set a target price of $90.0 on 06/24/2026
Vikram Kesavabhotla from Baird set a target price of $65.0 on 06/17/2026
Richard Close from Canaccord Genuity set a target price of $76.0 on 06/15/2026
Brian Peterson from Raymond James set a target price of $80.0 on 06/15/2026
Scott Schoenhaus from Keybanc set a target price of $90.0 on 06/12/2026
Ryan MacDonald from Needham set a target price of $76.0 on 06/11/2026
Saket Kalia from Barclays set a target price of $70.0 on 06/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.